Investors

Investor Contact Information

Lisa Caperelli
484-539-9736
lcaperelli@harmonybiosciences.com

Overview

Harmony Biosciences is a U.S. commercial-stage pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs. Established in 2017 by founder Paragon Biosciences LLC, our mission is to positively impact the lives of those living with rare diseases who are so often underserved.

Harmony has an experienced leadership team and a world class investor base, including affiliates of: Fidelity Management and Research Company; HBM Healthcare Investments; Novo Holdings; Paragon Biosciences, LLC; Valor Equity Partners; venBio Partners; Vivo Capital and Aisling Capital, among others. The company’s corporate headquarters are located in Plymouth Meeting, PA with offices in Chicago, IL and Washington DC.

Events and Presentations

More events are coming soon.

SHARE INFORMATION

Loading...

Corporate Governance

Code of Ethics and Conduct Policy

Corporate Governance Guidelines

Audit Committee Charter

Compensation Committee Charter

Nominating and Corporate Governance Committee Charter

2020 Quarterly and Annual Reports

More information coming soon.

2020 SEC Filings

S-1

8-K